cabozantinib,atezolizumab
exelixis,roche
['atezolizumab', 'cosmic021', 'cabozantinib', 'urothelial']
cabozantinib in combination with atezolizumab in #urothelialcarcinoma: results from cohorts 3, 4, 5 of the #cosmic021 study. presented by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology